Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.2 ug ml-1 | In vitro inhibition of L1210 murine leukemia cells by using MTT assay in cell culture | ChEMBL. | 2088342 |
IC50 (functional) | = 0.2 ug ml-1 | In vitro inhibition of L1210 murine leukemia cells by using MTT assay in cell culture | ChEMBL. | 2088342 |
IC50 (functional) | > 40 uM | Inhibition of tubulin polymerization | ChEMBL. | 2088342 |
IC50 (functional) | > 40 uM | Inhibition of tubulin polymerization | ChEMBL. | 2088342 |
T/C (functional) | = 100 % | In vivo inhibition of L1210 murine leukemia cells by using MTT assay in cell culture at a dose of 50 mg/kg | ChEMBL. | 2088342 |
T/C (functional) | = 100 % | In vivo inhibition of L1210 murine leukemia cells by using MTT assay in cell culture at a dose of 50 mg/kg | ChEMBL. | 2088342 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 2088342 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.